Antimicrobial Peptoid Selectivity via Local Quality
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The increasing problem of antibiotic resistance in bacteria, particularly multidrug-resistant bacteria, necessitates the development of new antimicrobial agents with differentiated mechanisms of action, and existing antimicrobial peptoids face challenges with cytotoxicity to animal cells.
Innovation Solution
The development of antimicrobial peptoids with specific sequences, including monomers like Nspe, NLys, NhTrp, NHis, and Npm, which exhibit reduced cytotoxicity and enhanced selectivity, are synthesized using solid-phase peptoid synthesis, incorporating an indole ring and cationic monomers, and undergo counter ion substitution to improve stability and activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antimicrobial peptoids are used to treat bacteria, then antimicrobial activity is improved, but cytotoxicity to animal cells increases
Solution Approach 1:
The patent applies local quality by modifying specific positions in the peptoid sequence (positions 2, 4, 6, 8, 10) with particular monomers (Nspe, NLys, NhTrp, NHis, Npm) to create regions of enhanced antimicrobial activity while maintaining regions of reduced cytotoxicity. The asymmetric distribution of cationic and hydrophobic monomers at specific locations enables selective interaction with bacterial membranes versus mammalian cells.
Solution Approach 2:
The patent changes key parameters including the charge-to-length ratio (optimizing cationic charge distribution), hydrophobicity (through Nspe and NhTrp monomers), and sequence composition (specific arrangements of 5 different monomers) to achieve enhanced antimicrobial activity while reducing cytotoxicity. The counter ion substitution process also modifies the chemical parameters to improve stability and selectivity.
2Reliability
If existing antibiotics are used, then bacterial infections are treated, but antibiotic resistance develops
Solution Approach 1:
The patent creates peptoid copies that mimic the structure and function of natural antimicrobial peptides but with improved stability and reduced resistance development. These peptidomimetic copies maintain the amphipathic structure and membrane-disrupting mechanism of natural AMPs while being resistant to proteolytic degradation, thereby providing sustained antimicrobial activity without the resistance issues of conventional antibiotics.
Solution Approach 2:
The patent employs composite peptoid structures combining multiple monomer types (Nspe, NLys, NhTrp, NHis, Npm) with different properties (hydrophobic, cationic, aromatic, heterocyclic) to create a composite molecular structure that achieves broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria, including multidrug-resistant strains, through a novel mechanism of action.
Data Source
AI summary
The present inventive concept relates to an antimicrobial peptoid having improved selectivity and an antimicrobial composition comprising same. The antimicrobial peptoid according to the present inventive concept exhibits excellent antimicrobial activity against bacteria and low cytotoxicity to animal cells by comprising an indole ring, introducing a cationic monomer thereinto, or comprising NHis as a submonomer containing imidazole on a side branch. Therefore, the antimicrobial peptoid of the present inventive concept has improved selectivity to bacteria and thus can be advantageously used for an antimicrobial composition.